Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | A. Zimmer, C. Peer, L. Cao, E. Kohn, S. Lipkowitz, C. Annunziata, J. Trepel, M-J. Lee, L. Mikkilineni, M. Gatti-Mays, A. Nunes, S. Soltani, W.D. Figg, N. Houston, E. Nichols, J-M. Lee | ||||||||||||
Title | A phase I study of durvalumab (D) in combination with olaparib (O) and cediranib (C) in recurrent women's cancers | ||||||||||||
|
|||||||||||||
URL | https://www.annalsofoncology.org/article/S0923-7534(20)37809-1/fulltext | ||||||||||||
Abstract Text | Ann Oncol 2017, Vol 28, Suppl 5, Abstract #390P |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|